OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Pharmaceutical Investigation is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Nitric oxide-releasing albumin/chondroitin sulfate bioadhesive dressing for the treatment of MRSA-infected wounds	223
Effects of telmisartan and perindopril combination on hypertension and cardiovascular damage	100
Emerging metabolic hormone therapeutics for metabolic dysfunction-associated steatohepatitis: incretin-based drugs, fibroblast growth factor analogs, and liver-targeting strategies	77
Applications of mesoporous silica particles in amorphous solid dispersion	67
Enhanced oral bioavailability of pranlukast by preparing amorphous solid dispersion via hot-melt extrusion	51
Development of prediction model with machine learning in continuous twin screw granulation	43
The combination of HDACi encapsulated liposomal vaccines with oncolytic peptide QR-KLU induces an immune-mediated abscopal effect for cancer immunotherapy	40
Recent advances in 3D cell culture models in cancer drug development	39
Recent advances in Alzheimer’s disease pathogenesis and therapeutics from an immune perspective	37
Comprehensive review in continuous direct compression process	32
Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery	29
Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients	28
Enhanced oral delivery of fenofibrate using PEGylated solid lipid nanoparticles	27
Self-amplifying ROS nanoplatform with dual responsiveness for tumor-targeted photodynamic therapy	27
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals	27
uPAR-targeted senolytic delivery to enhance cancer therapy	26
Organic clay-based fast dissolving microneedles for efficient transdermal delivery of therapeutic proteins	24
Prediction of the pharmacokinetics of the GLP-1 receptor agonist semaglutide in humans via a population pharmacokinetic model integrating interspecies scaling	24
Lyophilization of pharmaceuticals: an overview and practical approaches for developing the lyophilization cycle	23
A two-step design of experiments approach to investigate the simultaneous effects of ion-pairing and chemical enhancers to improve the permeability of lornoxicam in a topical hydrogel patch	22
Formulation of secretome derived from mesenchymal stem cells for inflammatory skin diseases	21
Theranostic potential and safety assessment of epirubicin-loaded SPIONs/PLGA-PEG nanoparticles in rabbit	21